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| INTRODUC TI ON
Acute-on-chronic liver failure (ACLF) is a syndrome characterized by acute decompensation (AD) of a patient with cirrhosis, combined with the development of multi-organ failure and a high short-term mortality rate. 1 Bacterial infections are considered the most frequent potential precipitating events in ACLF along with active alcoholism within the last 3 months and gastrointestinal haemorrhage. Bacterial infections are more frequently present in patients with ACLF as compared to patients with 'mere' AD of chronic liver disease (32.6% vs 21.8%, P < .001). 1 This higher frequency of bacterial infections in patients with ACLF was because of a higher prevalence of spontaneous bacterial peritonitis (SBP) (10.6% vs 5.6%; P < .01) and pneumonia (6.1% vs 2.2%; P < .01).
Bacterial infections are known to be associated with poorer clinical course and higher mortality in patients with ACLF. 2 Host defense mechanisms are impaired in patients with cirrhosis. Bacterial translocation, defined as the migration of bacteria or bacterial products from the intestinal lumen to mesenteric lymph nodes, 3 and the hyperdynamic circulatory state have been postulated to be key factors in the pathogenesis of infections in cirrhosis. 4 Gut microbiota, alterations in the intestinal mucosal barrier and innate immunity, the antigen nonspecific immune function, are all involved in bacterial translocation. 5, 6 The lectin pathway is part of the complement activation cascade in which molecules function as pattern recognition molecules to active processes of innate immunity. Lectins include ficolins (FNCs) and mannan-binding lectin (MBL) which are mainly produced by the liver. 7 FNCs are a group of oligomeric lectin proteins which recognize components of bacterial or fungal cell walls. 8, 9 MBL-associated serine proteases (MASP) can form complexes with MBL and FNCs, leading to activation of the lectin pathway, involving C3b-mediated opsonization of the pathogen and formation of the membrane attack complex. 10 Various single nucleotide polymorphisms (SNPs) in innate immunity genes with functional implications on protein levels have been described. Polymorphisms in the MBL2 gene, for instance, are known to affect proper lectin composition and impair its activity. [11] [12] [13] In patients with cirrhosis, deficiency in MBL protein serum levels is reported to be associated with an increased risk of and shorter time to developing bacterial infection. 14 Low levels of serum ficolin were found to be associated with a higher risk of occurrence of cirrhosis-associated bacterial infections. 15 Multiple other components are also involved in innate immune system signalling against pathogens, such as Toll-like receptor 2 (TLR2), Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MYD88) and nucleotide-binding oligomerization domain 2 (NOD2).
NOD2 and TLR receptors are involved in the intracellular recognition of bacterial pathogens and therefore are of key importance in the innate immune system. It is yet undefined whether SNPs with known functional implications in these innate immunity components are associated with bacterial infections or mortality in patients with decompensated cirrhosis or ACLF. In this study, we aimed to assess if functionally relevant polymorphisms in the lectin complement pathway and innate immune signalling components for pathogen recognition contribute to the susceptibility to bacterial infections and risk of mortality in cirrhotic patients hospitalized for AD or ACLF.
| PATIENTS AND ME THODS

| Study design
This study was performed as part of the CLIF Acute-on-chronic liver failure in cirrhosis (CANONIC) study, a prospective, observational, multicentre study aimed at identifying the diagnostic criteria of ACLF and to describe the development of this syndrome in European patients with AD. 1 Between February and September
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variants. None of the analysed SNPs were significantly associated with the occurrence of acute bacterial infections or spontaneous bacterial peritonitis in particular. Innate immune system-specific NOD2-G908R, MBL_Yx and MASP2_371 genetic variants were independently associated with increased risk of short-term mortality in AD/ACLF patients with bacterial infection.
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acute-on-chronic liver failure, bacterial infection, end-stage liver disease, innate immunity, single nucleotide polymorphism 2011, 1349 patients with cirrhosis hospitalized for AD were included in 29 hospitals in eight European countries. All 826 patients who gave informed consent for isolation and storage of DNA for future research with DNA available were included in this study.
This study was performed in accordance with the Declaration of Helsinki and approved by the ethics committees of all participating centres. 
| Genotype determination
Twenty-one genetic variants in the MBL2, FCN2, MASP2, TLR2, TLR4 and NOD2 genes with known functional implications on protein level were evaluated. [17] [18] [19] [20] Genomic DNA was extracted from 10 mL EDTA peripheral blood samples. Genotype identification was performed at the Leiden University Medical Centre, Leiden, The Netherlands. All genotypes were analysed using High-Resolution Melting Analysis (HRMA) with oligonucleotide primers, deoxyribonucleotide triphos-
phates (dNTPs), polymerase chain reaction (PCR) buffer FS-Taq
Polymerase and specific probe in the presence of fluorochrome LCgreen Plus. Detailed description of genotyping and assessment has been published previously. 17, 18 DNA fragments were visualized using a Idaho Technology Lightscanner. HRMA genotyping of NOD2 was not conclusive (data not shown), therefore it was performed with Biorad Realtime thermal cycler CFX96 with Precision Melt Analysis Software with oligonucleotide primers (Table S1) in the presence of SsoFast EvaGreen Supermix. All found genetic variants were validated by DNA sequencing. The investigators were blinded for clinical outcomes during genotype determination. European cohort minor allele frequencies of the 1000 Genome Project were used as reference of genetic variation. 21
| Statistical analysis
Associations between baseline characteristics of the patients, follow-up data and tested genetic variants were analysed by using the Mann-Whitney U test, Student's t test or Chi-square test when appropriate. The chi-squared test for Hardy-Weinberg equilibrium was used to evaluate the deviation of equilibrium. Multivariate logistic regression was used to evaluate the association between genetic variants and the occurrence of bacterial infection. Univariate and multivariate competing risks proportional hazards regression analysis was performed for prognostic factors of mortality using the method of Fine and Gray 22 with liver transplantation as competing risk event.
Univariate parameters were included at the P = .20 level and results with P ≤ .05 were considered to be statistically significant. The probability of survival within 90 days of follow-up according to the genetic variants was determined with cumulative incidence curves.
| RE SULTS
| Patient population
Clinical data and DNA samples were available for 826 patients with decompensated cirrhosis included in the CANONIC study. Within this group, 185 patients were diagnosed with ACLF at study enrolment and 78 patients developed ACLF during the follow-up period. Univariate analysis showed no association between individual SNPs and occurrence or grade of ACLF, therefore in the analyses no distinction was made between patients with ACLF or AD alone. Baseline clinical characteristics of all patients are shown in Table 1 . Mean age was 57.6 years and gender was predominantly male (63.6%). Main aetiologies of cirrhosis were alcoholic liver disease (60%) and hepatitis C (32.4%). The majority of patients had ascites at the time of inclusion in this study (89.7%). Patients with acute bacterial infection had higher baseline levels of CRP, WBC and clinical disease score (MELD score 21.6 vs 16.6, P < .001 and CLIF-C OF score 8.5 vs 7.1, P < .001). Previous prophylactic antibiotic use for SBP was lower in patients with acute bacterial infection (15.6% vs 9.7%, P = .016). In Table S2 , genotypes and allele frequencies are shown for all genotyped SNPs. Minor allele frequencies of all analysed genetic variants were comparable to previously reported frequencies of the European cohort in the 1000 Genome Project. 21 In some cases, available DNA quantity was not sufficient to obtain complete genotype for all polymorphisms. All allele frequencies were in Hardy-Weinberg equilibrium, except for MBL2_HL (P = .008), MASP2_371 (P = .008) and MD2_157 (P < .001). A homozygous NOD2 mutation was not detected in any patient. For 22 patients no information about the presence or absence of bacterial infection was available.
| Innate immunity genetic variants are associated with increased mortality
Univariate analysis between genetic variants and mortality showed that patients with a NOD2-G908R genetic variant had a significantly higher risk of mortality at 90 days of follow-up as compared to wildtype profile (5.7% vs 2.2%, P = .028), whereas patients with NOD2-R702W and NOD2-L1007FSINSC genetic variants showed no relation with decreased survival ( Table 2 ). Multivariate analysis for mortality at 90 days in all patients (n = 812) showed that NOD2-G908R (OR 2.25, P = .004) was the strongest predictor of mortality with liver transplantation as competing risk, along with age (HR 1.03, P < .001) and MELD score (HR 1.15, P < .001). In a predefined subgroup analysis in patients who developed acute bacterial infection at baseline or during 3 months after inclusion (n = 331), heterozygous genetic variants of NOD2-G908R (8.0% vs 0.9%, P = .002), MASP_371 (42% vs 25.8%, P = .012) and MBL_Yx (42.2% vs 31.8%, P = .056) were associated with increased mortality after 90 days of follow-up in comparison to the wildtype profile (Table 3 ). In a competing risk proportional hazards model, NOD2-G908R (HR 2.78, P < .001), MASP2_371 (HR 1.67, P < .012) and MBL_Yx (HR 1.72, P < .008) genetic variants were associated with worse survival at 90 days, independently of age and MELD score (Figures S1 and S2). (Table S3 ). In Table 4 , genetic variants in relation to bacterial infections with P ≤ .20 in univariate analysis are presented. In multivariate analysis, CLIF-C OF score (OR 1.61, P < .001) and WBC (OR 1.07, P < .001) were significantly associated with bacterial infection. Prophylactic antibiotic use for SBP during the whole study period showed a significant reduced risk for bacterial infection (OR 0.45, P = .004).
Variable
Presence of bacterial infection
P-value
| Acute bacterial infection
| NOD2-G908R, MASP2_371 and MBL_Yx haplotype
Three hundred and fifteen patients (38.7%) had no genetic variant of NOD2-G908R, MASP2_371 or MBL_Yx. Three hundred and sixtynine patients (45.3%) had one genetic variant present and 130 patients (16%) had two or more genetic variants. In univariate analysis, patients with a haplotype of one, or two or more genetic variants had a significantly increased mortality rate at 28 days (respectively 11% and 17% vs 7%, P = .001) and 90 days (21% and 25% vs 17%, P = .038) (Table S4 ). In a predefined subgroup analysis of patients with a bacterial infection (n = 326) and a haplotype of one, or two or more genetic variants, mortality was even higher as compared to patients without genetic variants at 28 days (respectively 24% and 33% vs 10%, P < .001) and 90 days (37% and 44% vs 20%, P < .001) ( We hypothesized that identification of genetic factors predisposing to systemic infections or mortality in cirrhosis could contribute to better preventive strategies and potential improvement of outcome in cirrhotic patients hospitalized for AD or ACLF. Such an approach might in time contribute to personalized treatment protocols, aiming to reduce bacterial infections as potential precipitating events of AD or ACLF and ultimately improved survival.
| D ISCUSS I ON
In this study we assessed the association between single nucleotide polymorphisms (SNPs) in the lectin complement pathway and innate immune signalling components for pathogen recognition and the occur- translocation. 23, 24 The association between NOD2 genetic variants Note: In univariate analysis only SNPs with P-value < .2 are presented, which were included in the multivariate analysis. In the multivariate logistic regression model CLIF-C score, WBC and prophylactic use of AB were taken as independent variables.
Abbreviations: CLIF-C OF, organ failure score for acute-on-chronic liver failure; SBP, spontaneous bacterial peritonitis; WBC, white blood cell. found that both NOD2-R702W and NOD2-L1007FSINSC were not associated with increased mortality whereas NOD2-G908R was associated with worse survival independently of age and MELD score. This finding may explain that no effect of NOD2 genetic variants on mortality was reported in the studies of Bruns and Dinya, since all NOD2 genetic variants were pooled together in those survival analyses. 25, 26 Another explanation for the difference in findings regarding survival In patients after liver transplantation, our group 17 found that single nucleotide polymorphisms in the MBL, MASP and FNC2 genes were major determinants for the occurrence of clinically significant bacterial infection and mortality. Furthermore, various studies showed that functional deficiencies of MBL, FNC and MASP serum protein levels lead to increased risk of bacterial infection in patients with cirrhosis. 14, 15 In our study we did not confirm that the genetic profile of the lectin pathway of complement activation had a major impact on the occurrence of bacterial infection in patients with decompensated cirrhosis. Serum protein levels of lectin pathway molecules were not determined in our study, therefore we could not assess if presence of a genetic variant correlated with clinically relevant deficiency of these molecules. However, NOD2-G908, MBL_Yx and MASP2_371 genetic variants were associated with a significantly higher short-term mortality in patients with an acute bacterial infection. The NOD2-G908 gene variant has previously been shown to be associated with increased translocation of bacterial DNA fragments in ascitic fluid in patients with culture-positive SBP. 24, 27 These studies support the functional relevance of this single nucleotide polymorphism. It may be hypothesized that these genetic variants are associated with a more severe clinical course in the presence of bacterial infection, rather than affecting the susceptibility of developing a bacterial infection. However, our study does not permit a conclusion in that respect. Strengths of this study were the large cohort of patients from different European centres which allowed us to study genetic variants individually and combined, the vigorous and uniform prospective collection of clinical data and blinding of the authors for clinical outcomes during genotyping of the SNPs. Limitations of this study were the testing of selected SNPs with known functional relevance, whereas an unbiased approach may provide new insights and the lack of information about bacterial infections occurring more than 3 months preceding inclusion in this study.
In conclusion, NOD2-G908R, MASP2_371 and MBL_Yx genetic variants were found to be independently associated with increased risk of short-term mortality in cirrhotic patients with decompensated cirrhosis or ACLF, particularly in those with bacterial infections. Functionally relevant polymorphisms in the lectin complement pathway and innate immune signalling components for pathogen recognition were not associated with Wim Laleman https://orcid.org/0000-0002-0842-7813
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